Skip to main content

Clarification: Jan 31, 2003

Premium

In the article detailing the wind-down of the Affymetrix and Agilent Technologies microarray scanner sales and distribution agreement published in the Jan. 10, 2003 edition of BioArray News, Ned Barnholt, the CEO of Agilent, said the company had concluded the arrangement. Agilent told BioArray last week that Agilent and Affymetrix have a scanner supply agreement in place through February 2003, and Affymetrix chose not to extend the agreement beyond that. There has been no agreement to end the contract early and “Agilent is honoring our obligations of the contract,” the company said.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.